semaglutide off the market obesity drug race just claimed another casualty. Zealand Pharma's shares collapsed on March 6, 2026, wiping billions its value after clinical data for its lead obesity candidate petrelintide failed Semaglutide Biosimilar and Generic Market

Contact our Carrollton clinic to schedule a consultation

In lactating cows, hindgut microbial-mediated secondary BAs metabolism was closely associated with plasma glucose and BHBA levels, mainly through remodeling taurine-conjugated and deconjugated BAs profiles to influence lipid absorption, suggesting the hindgut microbiotaBAs axis is critical for adapting to periparturient negative energy balance 85

In this context, a definite GPx3 target for optimal organ protection has not been established yet

(Photo illustration by Scott Olson/Getty Images) COLUMBIA Starting in January, South Carolinas Medicaid program will no longer cover weight loss drugs for obesity, reversing a year-old policy